Endomyocardial Fibrosis: an Update After 70 Years

Area of Science:

• Cardiology
• Tropical Medicine
• Pathogenesis Research

Background:

• Endomyocardial fibrosis (EMF) is a neglected tropical restrictive cardiomyopathy first described in 1948.
• Despite its poor prognosis, the etiology of EMF remains largely unknown.
• The changing endemicity and disease burden necessitate a deeper understanding of EMF.

Purpose of the Study:

• To review the current understanding of endomyocardial fibrosis pathogenesis and natural history.
• To highlight advancements in diagnostic tools and clinical management strategies.
• To identify future research directions for improving patient outcomes.

Main Methods:

• Literature review focusing on scientific discoveries and current concepts of EMF.
• Analysis of progress in diagnostic imaging techniques.
• Overview of emerging therapeutic targets for heart failure management.

Main Results:

• Novel diagnostic tools and improved clinical management options are emerging.
• Earlier diagnosis and potential for improved survival are linked to advancements in heart failure treatment.
• The etiology of EMF continues to be an area of active investigation.

Conclusions:

• A comprehensive understanding of EMF pathogenesis and natural history is crucial.
• Continued research into novel diagnostic and therapeutic approaches is essential.
• Focusing on new therapeutic targets may significantly improve outcomes for EMF patients.